"Bring Your Own Device" (BYOD): The Future of Field-Based Patient-Reported Outcome Data Collection in Clinical Trials?

被引:18
作者
Gwaltney, Chad [1 ]
Coons, Stephen Joel [2 ]
O'Donohoe, Paul [3 ]
O'Gorman, Hannah [4 ]
Denomey, Matthew [5 ]
Howry, Cindy [6 ]
Ross, Jennifer [7 ]
机构
[1] Brown Univ, ERT, Providence, RI 02912 USA
[2] Crit Path Inst, PRO Consortium, Tucson, AZ USA
[3] CRF Hlth, London, England
[4] Exco InTouch, Nottingham, England
[5] ICON, Wurzburg, Germany
[6] YPrime, Austin, TX USA
[7] Almac Clin Technol, Souderton, PA USA
关键词
clinical outcome assessments; patient-reported outcomes; electronic data capture; smartphone apps; diaries; study endpoints; PRO INSTRUMENTS;
D O I
10.1177/2168479015609104
中图分类号
R-058 [];
学科分类号
摘要
Field-based patient-reported outcome (PRO) assessments, including measures of signs, symptoms, and events that are administered outside of the research clinic, can be critical in evaluating the efficacy and safety of new medical treatments. Collection of this type of data commonly involves providing subjects with stand-alone electronic devices, such as smartphones, that they can use to respond to assessments in their home or work environment. Although this approach has proven useful, it is also limited in several ways: For example, provisioning stand-alone devices can be costly for sponsors, and requiring subjects to carry a device that is exclusively dedicated to the study can be burdensome. The Bring Your Own Device (BYOD) approach, in which subjects use their own smartphone or Internet-enabled device to complete field-based PRO assessments, addresses many of these concerns. However, the BYOD model has its own limitations that should be considered. In this article, representatives of the ePRO Consortium review operational, privacy/security, and scientific/regulatory considerations regarding BYOD. We hope that this review will allow researchers to make informed decisions when choosing methods to collect field-based PRO data in future clinical trials. Additionally, we hope that the discussion in this article will establish a research agenda for further examination of BYOD approaches.
引用
收藏
页码:783 / 791
页数:9
相关论文
共 50 条
  • [21] Feasibility of Tablet-Based Patient-Reported Symptom Data Collection Among Hemodialysis Patients
    Flythe, Jennifer E.
    Tugman, Matthew J.
    Narendra, Julia H.
    Dorough, Adeline
    Hilbert, Johnathan
    Assimon, Magdalene M.
    DeWalt, Darren A.
    KIDNEY INTERNATIONAL REPORTS, 2020, 5 (07): : 1026 - 1039
  • [22] Investigating the collection and assessment of patient-reported outcome data amongst unplanned surgical hospital admissions: A feasibility study
    Mason J.D.
    Blencowe N.S.
    McNair A.G.K.
    Stevens D.J.
    Avery K.N.
    Pullyblank A.M.
    Blazeby J.M.
    Pilot and Feasibility Studies, 1 (1)
  • [23] The use of computer touch-screen technology for the collection of patient-reported outcome data in rheumatoid arthritis: comparison with standardized paper questionnaires
    Salaffi, F.
    Gasparini, S.
    Grassi, W.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (03) : 459 - 468
  • [24] International perspectives on suboptimal patient-reported outcome trial design and reporting in cancer clinical trials: A qualitative study
    Retzer, Ameeta
    Calvert, Melanie
    Ahmed, Khaled
    Keeley, Thomas
    Armes, Jo
    Brown, Julia M.
    Calman, Lynn
    Gavin, Anna
    Glaser, Adam W.
    Greenfield, Diana M.
    Lanceley, Anne
    Taylor, Rachel M.
    Velikova, Galina
    Brundage, Michael
    Efficace, Fabio
    Mercieca-Bebber, Rebecca
    King, Madeleine T.
    Kyte, Derek
    CANCER MEDICINE, 2021, 10 (16): : 5475 - 5487
  • [25] Information about missing patient-reported outcome data in breast cancer trials is frequently not documented: a scoping review
    Krepper, Daniela
    Giesinger, Johannes Maria
    Dirven, Linda
    Efficace, Fabio
    Martini, Caroline
    Thurner, Anna Margarete Maria
    Al-Naesan, Imad
    Gross, Franziska
    Sztankay, Monika Judith
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2023, 162 : 1 - 9
  • [26] Patient-reported outcome instruments used in immune-checkpoint inhibitor clinical trials in oncology: a systematic review
    Colomer-Lahiguera, Sara
    Bryant-Lukosius, Denise
    Rietkoetter, Sarah
    Martelli, Lorraine
    Ribi, Karin
    Fitzpatrick-Lewis, Donna
    Sherifali, Diana
    Orcurto, Angela
    Juergens, Rosalyn
    Eicher, Manuela
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2020, 4 (01)
  • [27] Patient-reported outcome instruments used in immune-checkpoint inhibitor clinical trials in oncology: a systematic review
    Sara Colomer-Lahiguera
    Denise Bryant-Lukosius
    Sarah Rietkoetter
    Lorraine Martelli
    Karin Ribi
    Donna Fitzpatrick-Lewis
    Diana Sherifali
    Angela Orcurto
    Rosalyn Juergens
    Manuela Eicher
    Journal of Patient-Reported Outcomes, 4
  • [28] The design, implementation, and impact of an automated patient-reported outcome data collection and adverse event surveillance tool: a randomized trial
    Zhou, Megan S.
    Jain, Tanya
    Hardy, Nick
    Perez-Segura, Alejandro
    Hickman, Jasmine
    Leopold, Laurey
    Qualliotine, Kerry
    Yedidi, Raagini S.
    Whetsell, Matthew
    Broffman, Lauren
    BMC HEALTH SERVICES RESEARCH, 2023, 23 (01)
  • [29] The design, implementation, and impact of an automated patient-reported outcome data collection and adverse event surveillance tool: a randomized trial
    Megan S. Zhou
    Tanya Jain
    Nick Hardy
    Alejandro Perez-Segura
    Jasmine Hickman
    Laurey Leopold
    Kerry Qualliotine
    Raagini S. Yedidi
    Matthew Whetsell
    Lauren Broffman
    BMC Health Services Research, 23
  • [30] Patient-Reported Outcome Measurement in Clinical Dermatological Practice: Relevance and Feasibility of a Web-Based Portal
    van Cranenburgh, Oda D.
    ter Stege, Jacqueline A.
    de Korte, John
    de Rie, Menno A.
    Sprangers, Mirjam A. G.
    Smets, Ellen M. A.
    DERMATOLOGY, 2016, 232 (01) : 64 - 70